Skip to content

Clinical trials

Phase 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 3 Country / region: Japan Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20121
20141
20171
20192
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AbbVie1
Charite University, Berlin, Germany1
Japan Adult Leukemia Study Group1
Pfizer1
Princess Maxima Center for Pediatric Oncology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma7
Recurrence2
Burkitt Lymphoma1
Leukemia, Biphenotypic, Acute1
Leukemia, Lymphocytic, Chronic, B-Cell1
Leukemia, Myeloid, Acute1
Lymphoma, Large B-Cell, Diffuse1
Lymphoma, Non-Hodgkin1
Multiple Myeloma1
Neoplasms1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.